AstraZeneca, Hitachi to Jointly Research Pathogenesis and Prognosis of COPD

December 12, 2019
The Japan arm of AstraZeneca and Hitachi said on December 11 that they have inked a collaboration research agreement on the pathogenesis and prognosis of chronic obstructive pulmonary disease (COPD), aiming to publish a paper detailing the results next spring...read more